295330-38-0

Upstream product

• 132710-90-8 4-(3-hydroxy-propyl)-piperazine-1-carboxylic acid tert-butyl ester 
• 295330-86-8 tert-butyl 4-(3-((methylsulfonyl)oxy)propyl)piperazine-1-carboxylate 
• 184475-71-6 4-(3-chloro-4-fluorophenylamino)-6-hydroxy-7-methoxyquinazoline 
• 13794-72-4 3H-6,7-dimethoxyquinazolin-4-one 
• 179688-52-9 6-hydroxy-7-methoxyquinazolin-4(3H)-one 
• 179688-53-0 6-acetoxy-7-methoxy-3,4-dihydroquinazolin-4-one 
• 230955-75-6 6-acetoxy-4-chloro-7-methoxyquinazoline 
• 788136-89-0 4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl acetate 
• 912556-91-3 6-(3-chloropropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-ylamine 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 

Relevant academic research and scientific papers

IMMUNOPHILIN-DEPENDENT INHIBITORS AND USES THEREOF

Disclosed herein, inter alia, are immunophilin binding compounds and methods of using the same.

IMMUNOPHILIN BINDING AGENTS AND USES THEREOF

Described herein, inter alia, are immunophilin binding compounds and methods of treating CNS diseases, including co-administering outside the CNS of a subject an anti-CNS disease drug and a compound described herein.

Artemisin derivative and its preparation and use

Provided are artemisinin derivatives of formula (I) or pharmaceutically acceptable salts thereof, or enantiomers, diastereomers, and racemic bodies thereof, and a pharmaceutical composition of the compounds, the preparation process and uses thereof. Artemisinin derivatives of formula (I) have excellent effects in the treatment of tumours.

Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them

A compound of formula (I) wherein Ra, Rb, Rc, A, B, C, D, and X are as defined herein, or a tautomer, stereoisomer, or salt thereof, particularly a physiologically acceptable salt thereof. In addition, pharmaceutical compositions comprising an effective amount of a compound of formula (I), methods for the treatment or prophylaxis of benign or malignant tumors, diseases of the airways and lungs, polyps, diseases of the gastrointestinal tract, bile duct, gall bladder, kidneys, and skin, and methods for making compounds of formula (I) are disclosed.